The multiple sclerosis bladder consensus guidelines and pathway. One year on: where are we now?

Abstract

The multiple sclerosis (MS) bladder is associated with an increased risk of neurogenic problems that are distressing for people with MS (PwMS), as well as being a leading cause of hospital admissions. Almost all PwMS will have bladder symptoms after 10 years of living with the disease, which impacts their quality of life and has a huge economic burden on the NHS for problems including urinary tract infections (UTIs). Following the publication of updated MS bladder management guidelines and the development of MS bladder pathways, Sue Thomas outlines the implementation progress that has been made within the past year.